Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists. [electronic resource]
Producer: 20150819Description: 92-9 p. digitalISSN:- 1873-6815
- Aged
- Aged, 80 and over
- Aging -- metabolism
- Alzheimer Disease -- drug therapy
- Amidohydrolases -- antagonists & inhibitors
- Amyloid beta-Peptides -- metabolism
- Animals
- Arachidonic Acids -- metabolism
- Benzamides -- pharmacology
- Benzoxazines -- pharmacology
- Cannabinoid Receptor Agonists -- pharmacology
- Cannabinoids -- pharmacology
- Carbamates -- pharmacology
- Case-Control Studies
- Cerebral Cortex -- drug effects
- Endocannabinoids -- metabolism
- Enzyme Inhibitors -- pharmacology
- Female
- Frontal Lobe -- drug effects
- Humans
- In Vitro Techniques
- Male
- Middle Aged
- Morpholines -- pharmacology
- Naphthalenes -- pharmacology
- Polyunsaturated Alkamides -- metabolism
- Rats
- Rats, Wistar
- Synaptosomes -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.